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Cell Science-03 (CS-03)
Payload Overview
1 https://ntrs.nasa.gov/search.jsp?R=20180007351 2019-08-31T18:13:36+00:00Z
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• Vehicle: SpX-13
• Dates:  December 15th, 2017 –
January 13th, 2018
• Crew: 
• Joe Acaba performed the majority of 
CS-V operations
• Maker (Scott Tingle) performed 
bioreactor removal
• Nemo (Norishige Kanai) performed 
transfer to ISS
• Results: 
• 100% Science Return (8/8 
Bioreactors and 4/4 Samples)
• Received positive feedback on 
hardware in crew debriefs
Cell Science Validation (CS-V)
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Bioculture System
• Automated cell biology system with 10 independent cassettes
• Programmable manipulations include: 
• Media flow rate and feeding schedule
• Adjustable gas dosing
• Sample collection
• Fixative injection
• pH measurements
• Cassettes will be removed and opened in Life Sciences Glovebox (LSG) to allow 
initiation of cell cultures, media change out, sample retrieval and preservation.
• Hardware is ESD sensitive 5
Bioculture System
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The Power and Control Module takes 28V Rack voltage, converts it to 12V, and uses standard interfaces 
for both power and data to the Rack. The Power and Control Module contains an On/Off toggle switch, a 
circuit breaker, Data Connector, Power Connector, and two LEDs for Power/Fault Status. 
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Durable Cassette with Disposable Flow Path
8
8
Disposable Flow Path
9
Primary Bioreactor Preheat 
Reservoir Bag
Secondary 
Bioreactor
Bioreactor
Clamshell
ValvesOxygenator Pump
Media, Sump, 
Fixative, 
And Sample
Bags (3X)
9
*NOTE: Photo depicts current configuration of the 
Disposable Flow Path, including a secondary 
bioreactor containing growth factor beads. Testing 
is in-work and is required before final configuration 
will be determined.
CS-03 Experiment Summary
Principal Investigators Elizabeth Blaber, Ph.D.
Universities Space Research Association/
NASA Ames Research Center
Co-Investigators Eduardo Almeida, Ph.D
NASA Ames Research Center
Sponsor SLPSRA – Space Biology Program
Funding Authority NASA / Human Exploration & Operations / ISS
NASA / Human Exploration & Operations / Space Life and Physical Sciences
Experiment Title Osteogenic Differentiation of Somatic Stem Cells in Space: A Study 
Investigating the Role of CDKN1a/p21 on Mesenchymal Stem Cell 
Proliferation, Differentiation, and Regeneration in Microgravity.
Experiment Duration 30 Days – Initiated on orbit
Cell Type Mouse bone marrow mesenchymal stem cells 
Independent Variable Cell Type: Mesenchymal stem cells are isolated from 2 separate groups: 
Wildtype (WT) vs CDKN1a/p21 knockout (KO) mice
10
Launch
Schedule
CS-03 is currently scheduled for a SpX-18 launch (May 2019)
Duration of SpX-18 is 30 days from time of berth:
• Berth (5/9) – Unberth (6/8)
Duration
CS-03 experiment duration is 30 days.  The experiment will not be completed prior to 
SpX-18 unberth, so PD will request samples and hardware to be stowed for return on 
SpX-19.
11
New Crew Operations
Development of new crew operations will be finalized once the following documents and 
tests are completed:
• Experiment Requirements Document (ERD)
• Science Verification Test (SVT)
• Experiment Verification Test (EVT)
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New Crew Operations
MinION:
• Portable real-time device for DNA and 
RNA sequencing.
Bioreactor Injections:
• Frozen cells derived from two types of 
mice will be injected into the Bioreactors 
to initiate cultures.
Disposable Flow Paths:
• Current plan is the Disposable Flow Paths will 
be flown separately and the crew will install into 
the BCS Cassettes on-orbit.
Wet Lab RNA SmartCycler (Wet Lab-2):
• System will be used at two time points to verify 
expression of culture growth genes in sampled 
cells and finalized time of fixation.
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New Crew Operations
EdU Injection:
• 5-ethynyl-2’-deoxyuridine (EdU) will be 
injected into the primary bioreactor to 
label cellular DNA.
PFA Exchange:
• Cells will be sampled from the primary 
bioreactor and culture media from the 
sample will be replaced by 
paraformaldehyde (PFA).
PBS Exchange:
• PFA in syringes containing fixed cells will 
be replaced by phosphate buffered saline 
(PBS).
RNAprotect:
• Cells will be sampled from the primary 
bioreactor and mixed with RNAprotect
prior to hand over for Wet Lab-2 ops.
Growth Factor Beads Bioreactor 
Installation:
• An additional smaller secondary bioreactor with 
growth factor beads will be installed into each 
Disposable Flow Path prior to cell injection into 
the primary bioreactor.
Secondary
Bioreactor
14
*NOTE: Photo depicts current configuration of the 
Disposable Flow Path, including a secondary bioreactor 
containing growth factor beads. Testing is in-work and is 
required before final configuration will be determined.
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Integration Overview
• Bioculture System will be operational for 34 days after it is installed into the 
ExPRESS Rack
• Bioculture System Facility Payload Integration Agreement (PIA) Letter 
contains the following unique agreements:
• Bioculture System shall remain on the pad no longer than 48 hours after turnover, after 
which the medium shall be changed out
• Nominal turnover of unpowered Bioculture System
• Use of LSG for crew operations
• Use of SSPF labs at KSC pre-launch
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Integration Overview (Continued)
• Pre-flight specimen and hardware processing in the KSC SSPF
• On-orbit operations
• Majority of crew procedures already developed and executed on-orbit for CS-V (SpX-
13). 
• Updates for new operations for CS-03 are in work with POIC cadre
• Training Strategy: OBT
• Real-time support at ARC: Telemetry monitoring and commanding
• Requesting PD enablement and over-the-shoulder video during operations in LSG
• Use of ISS facilities:
• ExPRESS Rack
• Life Science Glovebox (LSG)
• MELFI (and Cold Stowage on Dragon – Polar and/or DCB)
• Wet Lab RNA SmartCycler
• MinION (TBD)
• Asynchronous Ground Control at ARC
• Post-flight science recoveries at PI laboratories. 
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Stowage Overview: Ascent on SpX-18
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 Cell Loading Kit (TBD)
 -80°C or colder
 Each 3mL syringe contains frozen cells
 Media Stowage Bag (x11)
 +4°C
 Each Media Stowage Bag contains five Media Bags 
(total of 45)
 Priming Media Stowage Bag (x4)
 +4°C
 Each Priming Media Stowage Bag contains five 
Media Bags (total of 20)
 Cell Sampling PFA Kit (x2)
 -20°C or colder
 Each contains five syringes
 EdU Kit (x2)
 -20°C or colder
 Each contains five syringes
 PBS Kit (x2)
 +4°C
 Each contains five syringes
 Growth Factor Beads Bioreactor Kit (TBD)
 +4°C
 Each contains five Bioreactors
Unpowered Locker
 Bioculture System
 Containing 10 Cassettes with no live cells
Cold Stowage
 Disposable Flow Paths (x10)
 Cassettes (x2)
 Spares
 Bag Changeout Kit (x4)
 Contains empty Sump Bags, Hemostats, Wipes, and other 
accessories
 One kit contains supplies for 10 cassettes.
 Bioreactor Removal Kit (x1)
 Contains Tube Cutter, two hard-sided Bioreactor 
Containers, and stowage bags
 Sample Bag Removal Kit (x3)
 Tube cutter and Sample Stowage Bags
 Gas Supply (x3)
 Replacement Gas supplies to be installed during gas 
supply changeout
 Setup Kit (x1)
 Items for setting up LSG (wipes, O-rings)
 Accessories Kit (x1)
 Spare syringes, hemostats, caps, wipes, etc
 Cell Sampling RNAprotect Kit (x2)
 Syringes with RNAprotect
Soft Stowage
Stowage Overview: Descent on SpX-19
 Bioreactor Container (x2)
 -80°C
 Each container will have five individually 
bagged Bioreactors
 Sample Stowage Bag (TBD)
 -80°C
 Return Bag (TBD)
 -80°C (Media Bags)
 Return Bag (TBD)
 -80°C (Sump Bags)
 Wet Lab-2 Sample Return Vial (x12)
 -80°C 
 MinION Sample Return Bag (TBD)
 -80°C
 PFA Preserved Sample Return Bag (TBD)
 +4°C
Cold Stowage Soft Stowage
 Bioculture System
 Will be unpowered, removed from ExPRESS 
Rack, and packed in foam following 
conclusion of the experiment.
 Will require oversize bag
 Needs to be priority return to ARC
 Gas Supply (x3)
 Used gas supplies for refurbishment
 Cassettes (x2)
 Spares returned
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CS-03 Hypothesis and Objectives
Hypothesis: Based on PI’s previous results, CDKN1a/p21 may be a key molecular 
mechanism in the control of stem cell based tissue regeneration and is therefore a key 
candidate for stem cell-based tissue regenerative therapies and investigation in 
microgravity. This study hypothesizes that CDKN1a/p21 inhibits the proliferation and 
differentiation of mesenchymal stem cells into bone forming osteoblasts in space 
environment. Therefore, bone marrow mesenchymal stem cells from the CDKN1a/p21-
null mice are expected to show unrestrained proliferation and differentiation in 
microgravity. 
Objectives:
• Specific Aim 1: Assess the in-vitro proliferation, differentiation, and 
mineralization capacity of bone marrow mesenchymal stem cells isolated from 
CDKN1a/p21-null mice compared to wild-type animals in microgravity versus 1g 
controls.
• Specific Aim 2: Determine cellular mechanisms associated with alterations in 
osteoprogenitor differentiation potential in CDKN1a/p21-null mice versus wild-
type controls
• Specific Aim 3: Investigate the signal transduction pathways, specifically NFκB, 
MAPK, and Pi3K signaling, which are responsible for activation of CDKN1a/p21 
in microgravity and therefore inhibition of in vitro bone formation in space. 21
